We investigated the effects of inducing deep remission in patients with early Crohn's disease (CD).

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease / Ungaro, Ryan C; Yzet, Clara; Bossuyt, Peter; Baert, Filip J; Vanasek, Thomas; D'Haens, Geert R; Joustra, Vincent Wilhelmus; Panaccione, Remo; Novacek, Gottfried; Reinisch, Walter; Armuzzi, Alessandro; Golovchenko, Oleksandr; Prymak, Olga; Goldis, Adrian; Travis, Simon P; Hébuterne, Xavier; Ferrante, Marc; Rogler, Gerhard; Fumery, Mathurin; Danese, Silvio; Rydzewska, Grazyna; Pariente, Benjamin; Hertervig, Erik; Stanciu, Carol; Serrero, Melanie; Diculescu, Mircea; Peyrin-Biroulet, Laurent; Laharie, David; Wright, John P; Gomollón, Fernando; Gubonina, Irina; Schreiber, Stefan; Motoya, Satoshi; Hellström, Per M; Halfvarson, Jonas; Butler, James W; Petersson, Joel; Petralia, Francesca; Colombel, Jean-Frederic. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - 159:1(2020), pp. 139-147-147. [10.1053/j.gastro.2020.03.039]

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

Danese, Silvio;
2020-01-01

Abstract

We investigated the effects of inducing deep remission in patients with early Crohn's disease (CD).
2020
Adalimumab
CDEIS
IBD
Inflammatory Bowel Diseases
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119547
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 124
  • ???jsp.display-item.citation.isi??? 109
social impact